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An N-Terminal Method for Peptide Solubilisation 
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Biochemistry Department, Groningen Biomolecular Sciences and Biotechnology Institute, University of 
Groningen, Nijenborgh 4, Groningen 9747AG, The Netherlands 
Received 4 September 1998; revised 22 March 1999; accepted 31 March 1999 
Abstract: Peptide-constructs of the form (solubilising peptide)-[NH(CH2)2SO2(CH2)20-CO]-(insoluble 
peptide) were synthesised by Boc SPPS. The HPLC-purified peptide-constructs were cleaved with 
aqueous base to liberate the insoluble peptides as precipitates. © 1999 Published by Elsevier Science Ltd. 
All fights reserved, 
Keywords: Peptides and polypeptides; Solid phase synthesis; Cleavage r actions, 
INTRODUCTION 
In previous papers we described SPPS strategies for rendering hydrophobic peptides oluble by linking 
them at their C-terminus, via an orthogonally cleavable linkage, to hydrophilic solubilising peptides, t3 One 
deficiency of the C-terminal solubilisation method was that peptide amides were not readily obtainable. We 
therefore investigated a complementary N-terminal peptide solubilisation method. N-terminal peptide 
solubilisation required an N-terminal linkage which would be stable to all conditions of peptide synthesis, 
cleavage, and purification, and yet later be readily cleavable. The linker compound 2-[{(N-t-Boc)-2- 
aminoethyl}sulphonyl]ethyl p-nitrophenyl carbonate 6 appeared to have potential in such an application. 4 
However, use of this linker in subsequent SPPS of the type of N-terminally-linked peptide-construct shown in 
Figure I a has not, to our knowledge, been reported. 
0040--402019915 - see front matter © 1999 Published by Elsevier Science Ltd. All rights reserved. 
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Sol. Peptide-[NHCH2CH2SO2CH2CH20-CO]-Insoluble Peptide 
b Sol. Peptidel -[NHCH2CH2SO2CH2CH20-CO]-Insoluble Peptide-[OCH2-~O]-Sol, Peptide 2 
Figure 1. a) N-terminally, and b) N- and C-terminally solubilised peptides. 
Urethane linkages based on 6 are cleaved by aqueous base, 4"6 i.e. the same conditions used to cleave the 
base-labile glycolamide ster I or 4-hydroxymethylbenzoic acid-derived [4-Hmb] 2'3 ester linkages used in the C- 
terminal solubilisation methods. Identical cleavage conditions would allow long hydrophobic peptides to be 
synthesised with both N- and C- terminal solubilising peptides, giving peptide-constructs of the type shown in 
Figure lb. Following HPLC purification the N- and C-terminal solubilising peptides of such a construct could 
be cleaved by a single treatment with aqueous base. In this paper we present an alternative synthesis of linker 6, 
and describe its use in Boc SPPS of solubilised peptide-constructs of the types shown in Figure 1. 
RESULTS AND DISCUSSION 
Linker compound 6 was synthesised as shown in Scheme 1. N-t-Boc cystamine 2 was prepared using a 















t-Boc-N HCH2CH2SO2CH2CH20-CO-O'-~ NO2 
Scheme 1. Synthesis of the linker 2-[{(N-t-Boc)-2-aminoethyl}sulphonyl]ethyl p-nitrophenyl carbonate 6.
i) di-tert-butyl pyrocarbonate; ii) tri-n-butylphosphine; iii) 2-chloroethanol / NaOH; iv) H202; 
v) 4-nitrophenyl chloroformate / pyridine. 
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cysteamine 3 using tri-n-butylphosphine, rather than the more expensive dithiothreitol (DTT). 7 Reaction of 3 
with 2-chloroethanol by a slightly modified literature method 8 gave 2-[S-{(N-t-Boc)-2-aminoethyl}]mercapto- 
ethanol 4. Hydrogen peroxide oxidation of 4 in the presence of a sodium tungstate catalyst 5'6 gave 2-[{(N-t- 
Boc)-2-amint~thyl}sulphonyl]ethanol 5. Finally, reaction of 5 with 4-nitrophenyl chloroformate yielded 2- 
[ { (N-t-Boc)-2-aminoethyl}sulphonyl]ethyl p-nitrophenyl carbonate 6.4"6 The overall yield of linker 6 was 45% 
based on cystamine 1, which may be compared to the 29% overall yield of an alternative synthetic route to 6. 4 
In the final step (Scheme 1, v) TLC analysis alter four days reaction showed a ratio of starting material 5 to 
product 6 of approximately 1:4. Further optimisation of this final step should result in greater yields of 6. 
Peptides were synthesised by manual Boc SPPS methods. 9 Linker 6 was reacted with the N-terminal 
amino groups of resin-bound synthetic peptides, the Boc group of the linker was removed, and a second, 
solubilising peptide was synthesised togive resin-bound peptide-constructs of the form Peptider[Ntl]-Peptide2- 
(Resin). We used the abbreviation [Ntl] (for N-terminal _linker) to signify the -[NHCH2CH2SO2CH2CH2OCO]- 
linkage between the two peptides. Peptide-resins were cleaved using liquid HF with p-cresol and p-thiocresol 
as scavengers, and worked-up using normal procedures. The N-terminal peptide solubilisation strategy, using 




[t-Boc-NHCH2CH2SO2CH2CH20-COI-PQFVQNINIEN LFR-[MBHAI-(PS resin) 






Scheme 2. Strategy for N-terminal solubilisation ofhydrophobic and poorly soluble peptides using CP1042-55- 
amide (PQFVQNINIENLFR-amide) as an example, i) 2-[ {(N-t-Boc)-2-aminoethyl } su phonyl]- 
ethyl p-nitrophenyl carbonate (6) in 5% DIEA / DMF; ii) Boc SPPS; iii) HF cleavage; iv) HPLC 
purification; v) 0.1 M NaOH. 
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The first test peptide studied was PQFVQNINIENLFR-amide (CP 1042"ss-amide).l'l° Although apparently 
a relatively simple sequence, in practice this synthetic peptide has been difficult to purify owing to its tendency 
to form insoluble intermolecular ggregates. CP1042"sS-[MBHA]-resin was reacted with linker 6, and after Boc 
removal the solubilising tail peptide (RGG)3-G was synthesised. An HPLC chromatogram of crude cleaved 7
(Figure 2a) showed two major components. The mass of peak 1 (2779.0 Da) coincided with that calculated for 
(RGG)3-G-[Ntl]-CP1042"55-amide 7 (2779.1 Da, MH+), while peak 2 was a side product of mass 2836 Da (+57 
Da). An additional mass of +56 Da usually corresponds toa peptide t-butyl adduct. Initial studies of peak 2 
have shown that he extra mass of 57 Da is located within the CP 1042"ss portion of peptide-construct 7 (data not 
shown). If the extra mass of 57 Da in HPLC peak 2 is due to a t-butyl adduct, it is likely to have accumulated 
during the repetitive Boc deprotection steps, as the N-terminal Boc group was removed before the peptide was 
cleaved from the resin. Investigations into the exact nature of the +57 Da adduct are continuing. 
a b 
2 
i . . . .  i . . . .  I . . . .  ! . . . .  
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Figure 2. HPLC chromatograms of a) crude (RGG)3-G-[Ntl]-CPI042-ss-amide 7; b) HPLC purified 7. 
Peptide-construct 7 was purified by standard HPLC methods (Figure 2b). The [Ntl] linkage of 7 
(2 mg/ml) was cleaved by 0.1 M NaOH within 60 seconds. After ¢entrifugation of the subsequently acidified 
solution mass pectral analysis of the supematant showed (RGG)3-G-[NHCHzCH2SO2CH=CH2] 8 to be present 
(found 1003.7 Da, calc. MH+ 1003.9 Da), whereas CP1042SS-amide 9 was not detected (1732 Da, Figure 3a). 
A study of cleavage of the [Ntl] linkage of 7 (2 mg/ml) at lower NaOH concentrations showed only partial 
cleavage with 0.01 M NaOH over 120 seconds, and almost no cleavage with 0.001 M NaOH over the same 
time. 
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The gel-like precipitate of CP1042"ss-amide 9, resulting from cleavage with 0.1 M NaOH, was washed 
several times with water, and dissolved in acetic acid for mass analysis (Figure 3b: found 1731.7 Da, talc. MH+ 
1731.9 Da). Mass analysis howed that he precipitate of 9 was highly homogeneous. 
a 1003.7 b 1731.7 
100- 100- 
% 
**"560 15bo '~obo 
mass/Da 
%. 
n . . . . . . . . . .  . . . . . . .  , 
mass/Da 
Figure 3, MALDI-TOF mass spectra of: a) supematant from NaOH cleavage of (RGG)3-G-[Ntl]-CP 1042-55- 
amide 7 showing soluble cleavage product (RGG)3-G-[NHCH2CH2SO2CH=CH2] g (calc. mass 
MH+ 1003,9 Da); b) precipitate ofCP1042"SS-amide 9 dissolved in acetic acid (calc, mass MH+ 
1731,9 Da), 
A second peptide to be synthesised was the N- and C- terminally solubilised peptide-construct (RGG)3-G- 
[Ntl]-AIa~2-[4-Hmb]-GG(RG)4G 11. This example was chosen to investigate use of the N-terminal linkage in 
combination with the acid-stable, base-labile ester based on 4-hydroxymethylbenzoic ac d(4-Hmb linker) used 
in the C-terminal solubilising method. 2'3 The course of the synthesis was monitored by cleavage of the peptide- 
resin at intermediate stages, with analysis by HPLC and MALDI-TOF mass spectrometry. Mass spectral 
analysis of A-[4-Hmb]-GG(RG)4G, cleaved at such an intermediate stage, showed a main product of the 
expected mass (found 1247.1 Da, calc. MI-I+ 1248.3 Da) with only very low levels of unwanted deletion 
peptides (data not shown). This analysis howed that all steps up to this point had gone in high yield. It was 
found that by coupling 4-hydroxymethylbenzoic ac das its NHS active ester, di-addition of the 4-Hmb linker 
was avoided, a problem noted when HBTU was used to couple this linker. 2 
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An HFLC chromatogram of AI2-[4-Hmb]-GG(RG)4G 10 showed that the intermediate peptide was of 
acceptable purity, with the major product eluting at 12.7 minutes having a mass of 2029.4 Da (Figure 4a, calc. 
for 10 MH+ 2030.2 Da). An HPLC chromatogram of crude cleaved (RGG)3-G-[Ntl]-Alal2-[4-Hmb]- 
GG(RG)4G 11 is given as Figure 4b. The mass of the major peak eluting at 15.0 minutes (3075.8 Da) was as 
calculated for 11 (MH+ 3077.3 Da). 
a ,12.7 b 15.0 
Figure 4. HPLC chromatograms of a) crude A12-[4-Hmb]-GG(RG)4G 10; b) crude (RGG)3-G-[Ntl]-Alal2- 
[4-Hmb]-OG(RG)4G 11. 
HPLC-purified 11 (2 mg/ml) was cleaved with 0.1 M NaOH for 60 seconds, acidified with acetic acid, 
and centrifuged. The mass of the precipitate which formed (872.0 Da ) corresponded toAlal2 12 (calc. MH+ 
872.2 Da). Peptides with masses of 1002.6 Da and 1177.0 Da were present in the supematant, and these 
corresponded tothe expected soluble cleavage products (RGG)3-G-[NHCH2CH2SO2CH=CH:] 13 (calc. MH+ 
1003.9 Da), and [HOCH2-C6I-I4-CO]-GG(RG)4G 14 (calc. MH+ 1177.3 Da) respectively. No uncleaved 11 was 
found by both HPLC and MALDI-TOF analysis of the supematant, showing complete cleavage of the 4-Hmb 
and [Nil] linkages within 60 seconds using 0.1 M NaOH. 
HPLC and MALDI-TOF analyses of the supematant from a solution of 11 (2 mg/ml) cleaved using 0.01 
M NaOH for 120 seconds howed masses corresponding to the expected cleavage products 13 and 14, but in 
addition a product with mass 2030.5 Da was present. This mass corresponded toAI2-[4-Hmb]-GG(RG)4G 10 
(calc. MH+ 2030.2 Da), and indicated incomplete cleavage of the 4-Hmb ester. Despite incomplete cleavage of 
the 4-Hmb linkage it must be noted that the [Ntl] linkage of 11 was completely cleaved in 120 seconds using 
0.01 M NaOH. 
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In the NaOH cleavage of the [Ntl] linkages of peptide-constructs 7 and 11 it was found that 7 required 
treatment with 0.1 M NaOH for 60 seconds for complete cleavage of the [Ntl] linkage. On the other hand the 
[Ntl] linkage of 11 was cleaved in 60 seconds with 0.01 M NaOH, although 0.1 M NaOH was required for 
complete cleavage of the 4-Hmb ester of 11. This data suggests dependence of the rate of cleavage of the [Ntl] 
linkage on the N-terminal amino acid. As a general rule we conclude that the [Ntl] linkage should be cleaved 
with 0. I M NaOH for at least 60 seconds. 
After cleavage of the C- and/or N-terminal solubilising peptides the target hydrophobic peptides were 
obtained as gel-like precipitates. Mass analysis of the precipitate of CP 1042"55-amide 9 (Figure 3b) showed it to 
be homogeneous. Analysis of Alal2 12 was complicated by its extremely poor solubility, however mass 
analysis of a suspension of the Ala12 precipitate in the MALDI-TOF matrix solution did show an Alat2 ion to be 
present, albeit at low intensity (data not shown). Since the precipitates of the desired hydrophobic peptides 
were derived from homogeneous purified peptide-construets they were expected to be of good purity after 
cleavage of the 4-Hmb and/or [Ntl] linkages. 
CONCLUSIONS 
We have reported an N-terminal Boc SPPS peptide solubilising strategy which is compatible with modem 
optimised Boc SPPS methods, 9 and can be used in combination with our previous C-terminal solubilisation 
method.l'3 A strength of this strategy is that the water-soluble peptide-constructs ould be purified by standard 
HPLC methods, a distinct advantage over specialised, peptide-specific HPLC methods used to purify 
hydrophobic peptides, j l Further uses of this strategy include: i) "rescuing" a resin-bound peptide which proves, 
against prior expectations, tobe poorly soluble (CP1042-55-arnide is a good example of such a peptide); ii) use as 
a method for attaching a removable peptide "tail" to the N-terminus of another synthetic peptide (e.g. to attach a 
His6 tag for Ni-Agarose affinity purification); and iii) solubilising peptide components for subsequent synthesis 
of long hydrophobic peptides by chemical ligation - such an arrangement is compatible with thioether 
ligation. 3'12 Other applications of this peptide modification strategy are also under investigation. 
EXPERIMENTAL 
Thin layer chromatography was carried out using Merck Kieselgel 60/Kieselgur F254 plates. Solvent 
systems (all v/v) were: System 1, butanol:acetic a id:water 4:1:1; System 2, hexane:ethyl acetate 4:1; System 3, 
hexane:ethyl acetate 1:4; System 4, hexane:ethyl acetate:acetic a id 50:50:1; System 5, hexane:ethyl acetate 
1:1. Plates were visualised with either ninhydrin spray (1% w/v in ethanol) followed by heating at 100°C or 
iodine vapour. NMR spectra were recorded using a Varian Gemini 200 (200 MHz) instrument. Perkin Elmer 
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model 841 scanning (compounds 4 and 5) or Mattson Instruments model 4020 FT-IR (compound 6, KBr disc) 
spectrophotometers were used to record IR spectra. 
N-t-Boo cysteamine (3). N-t-Boo cystamine 2 (7.175 g, 20.4 mmole), synthesised using a literature 
method (yield 99.6% based on cystamine 1, TLC: System 1 Rf I = 0, Rf 2 = 0.97), 7 was suspended in a mixture 
of 100 ml isopropanol and 100 ml 0.5 M NaHCO3, and tri-n-butyl phosphine (5.3 ml, 21.3 mmole) was added 
with stirring. After 50 minutes, TLC of the cloudy solution (System 2, Rf 2 = 0.36, Rf N-t-Boe-cysteamine 3 = 
0.61) showed complete reduction of 2 to 3. Isopropanol was removed in vacuo, 50 ml water and 50 ml 
saturated NaCI solution were added, and the solution was extracted twice with 100 ml aliquots of ethyl acetate. 
The combined organic layers were back-extracted xtensively with 1 M HC1 (10 x 200ml) to remove tri-n-butyl 
phosphine oxide, dried with Na2SO4, and ethyl acetate was removed in vacuo. The resulting oil, containing 
traces of ethyl acetate, was subjected to a stream of dry nitrogen until constant weight. The N-t-Boc-cysteamine 
3 which resulted, a clear colorless oil (6.92 g, 36.4 mmole, 89% [93% purity]), was devoid of the characteristic 
odour of tri-n-butyl phosphine, however NMR analysis howed the presence of 7% tri-n-butyl phosphine oxide 
as an impurity. This harmless impurity was carried through in the subsequent reactions. IH NMR (CDCI3): 6 
4.92 (br m, 1 H, ex D:O), 3.29 (m, 2 H), 2.63 (m, 2 H), 1.44 (s, 9 H), 1.34 (t, 1 H, ex D20). 
2-[S-{(N-t-Boc)-2-aminoethyl}] mercaptoethanol (4). A solution of sodium hydroxide (1.60 g, 40.0 
mmole in 3 ml water, then mixed into 30 ml ethanol) was added, with stirring, to a solution of N-t-Boc- 
cysteamine 3 (6.92 g 39.1 mmoles) and 2.70 ml 2-chloroethanol (40.3 mmole) in 20 ml ethanol. The initially 
colorless olution went yellow on adding the NaOH solution, and a white precipitate of NaCI formed within 
five minutes. After stirring for 20 minutes TLC (System 2, Rf 3 = 0.61, Rf product 4 = 0.11) showed that 
reaction was complete. Ethanol was removed in vacuo, water (100 ml) was added and the aqueous olution 
was extracted with two 100 ml aliquots of ethyl acetate. The combined organic layers were dried with Na2SO4, 
and the ethyl acetate was removed in vaeuo to give 2-[S-{(N-t-Boc)-2-aminoethyl}]mercaptoethanol 4 as an oil. 
The clear colourless oil was subjected to a stream of nitrogen to remove residual ethyl acetate, and then dried 
under vacuum overnight until the weight was constant. NMR analysis showed the presence of Iri-n-butyl 
phosphine oxide impurity as 7% of the mass of the product (8.13 g, 34.2 mmole, 87% [93% purity]). IH NMR 
(CDCI3): 8 4.91 (br m, 1 H, ex D20), 3.74 (t, 2 H, J--5.9 Hz), 3.32 (m, 2 H), 2.74 (t, 2 H, J--5.9 Hz), 2.65 (t, 2 
H, J=6.6 I-Iz), 2.23 (br s, 1 H, ex D20), 1.44 (s, 9H). IR: 3354 em "l, 2977 cm "l, 1701 em "l, 1521 cm "l, 1274 era" 
i, 1250 cm "1, 1164 em "l, 1045 cm "l. Elemental analysis: Calculated for 2-[S-{(N-t-Bec)-2- 
aminoethyl}]mereaptoethanol. 0.07 tri-n-butyl phosphine oxide (C9HI9NO3S. 0.07CI2H27PO): C, 49.98; H, 
8.84; N, 5.93; S, 13.54. Found: C, 49.67; H, 8.92; N, 5.68; S, 13.39. 
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2-[{(N-t-Boc)-2-aminoethyl}sulphonyilethanol (5). A catalytic amount of sodium tungstate (120 mg) 
dissolved in 20 ml water was added to a solution ofoil 4 (8.13 g, 34.2 mmole) in 50 ml ethanol. The mixture 
was stirred while 3.8 ml 30% H202, sufficient o oxidise the thioether to the sulphoxide, was added dropwise 
over five minutes. TLC (System 3, Rf 4 = 0.69, reaction Rf = 0.46) showed the disappearance of the starting 
compound 4. Another 3.8 ml H202 was added over five minutes as above, and TLC now showed a single spot 
of product 5 (Rf= 0.54). After two hours stirring 0.50 g NaHSO4 in 80 ml water was added to decompose any 
remaining H202. Ethanol was removed in vacuo and the solution was extracted with three 100 ml aliquots of 
ethyl acetate. The combined organic layers were back-extracted twice with 25 ml saturated NaC1 solution, dried 
with Na2SO4, and then dried overnight over 4A molecular sieves. Ethyl acetate was removed in vacuo and the 
clear colourless oil was dried to constant weight with a flow of nitrogen to give 2-[{(N-t-Boc)-2- 
aminoethyl}sulphonyl]ethanol 5 c ntaining 7% tri-n-butyl phosphine oxide (8.32 g, 30.6 mmole, 83% [93% 
purity]). IH NMR (CDCI3): ~ 5.26 (br m, 1 H, ex D20), 4.10 (t, 2 H, J=5.1 Hz), 3.64 (m, 2 H), 3.33 (t, 2 H, 
J=6.1 Hz), 3.24 (t, 2 H, J=5.1 Hz), 2.66 Cor s, 1 H, ex D20), 1.43 (s, 9H). IR: 3359 crn "l, 2979 cm l,  1714 cm l,  
1520 cm l,  1285 cm "l, 1254 cm "l, 1168 cm -1, 1122 cm l,  1045 cm 1. Elemental analysis: Calculated for 2-[{(N- 
t-Boc)-2-aminoethyl}sulphonyl]ethanol. 0.07 tri-n-butyl phosphine oxide (C9HI9NOsS. 0.07CI2H27PO): C, 
44.02; H, 7.79; N, 5.22; S, 11.93. Found: C, 43.83; H, 8.01; N, 4.94; S, 12.18. 
2-[{(N-t-Boe)-2-aminoethyl}suiphonyl]ethyl p-nitrophenyl carbonate (6). Compound 5 8.32 g (30.6 
mmole) was dissolved in 50 ml dry pyridine at 0°C, and 4-nitropbenyl chloroformate (6.70 g, 33.2 mmole) was 
added over two minutes with stirring. After two hours at 0°C the solution was brought o room temperature. 
The course of the reaction was followed by TLC (System 4, gr 5 -- 0.13, Rf product 6 = 0.48). After stirring 
overnight the reaction was incomplete. Extra 4-nitrophenyl chloroformate (3.30 g, 16.4 mmole) was added and 
stirring was continued. After four days pyridine was removed in vacuo to give a yellow oil, which was 
dissolved in 100 ml ethyl acetate and extracted with 100 ml 1 M HC1. The HCI solution was back-extracted 
with 100 ml ethyl acetate, the organic layers were combined, extracted twice with 25 ml saturated NaC1 
solution, and dried over Na2SO4. Ethyl acetate was removed in vacuo yielding a yellow oil. Ether (50 ml) was 
added to the oil and the solution was left to stand overnight. A precipitate which formed was collected, washed 
with a little ether, and dried under vacuum (9.54 g). TLC of the solid (System 5) showed two spots Rf = 0.16 
(5) and 0.55 (6). The solid was dissolved in 20 ml ethyl acetate with heating and 30 ml hexane was slowly 
added. After cooling to room temperature and standing for five hours the resulting precipitate, a white solid, 
was collected and washed twice with 8 ml hexane:ethyl acetate 1:1. The weight of vacuum-dried product 2- 
[{(N-t-Boc)-2-aminoethyl}sulphonyl]ethyl p-nitrophenyl carbonate 6 was 7.69 g, (18.4 mmoles, 56%). Melting 
point 117-119"C (dee., uncorr.). The overall yield of 6 was 45% based on eystamine 1. IH NMR (CDCI3): 8 
8.29 (d, 2H, J=8.5 Hz), 7.40 (d, 2H, J=8.5 Hz), 5.15 (br m, 1H), 4.73 (t, 2H, J=5.2 Hz), 3.68 (m, 2H), 3.46 (t, 
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2H, J=5.2 Hz) 3.34 (t, 2H, J-- 5.5 Hz), 1.43 (s, 9H). IR: 3376 cm "l, 2292 cm "t, 1765 cm "l, 1682 cm "l, 1534 
cm "l, 1265 cm "l, 1221 cm "l, 1196 em "l, 1134 em "l, 1057 em "1. Elemental analysis: Calculated for 2-[{(N-t- 
Boc)-2-aminoethyl}sulphonyl]ethylp-nitropbenyl car o ate (CI6H22N2098): C, 45.93; H 5.26; N, 6.70; S, 7.66. 
Found: C, 45.97; H, 5.31; N, 6.65; S, 7.44. 
Solid phase peptide synthesis. Peptides were synthesised by manual Boc SPPS with in-situ 
neutralisation. 9 Side chain protecting roups were Ash (Xan), Arg (Tos), Gin (Xan) and Glu (OBzl). Dried 
peptide-resins were cleaved over 90 minutes at 0°C using HF/p-tl~ocresol/p-cresol 18:l:l v:v:v. After 
removing HF in vacuo, the peptides were precipitated with 50 ml ether, stirred for 5 minutes at 0°C, filtered off, 
washed with 2 × 25 ml ether, dissolved in 1 ml TFA, diluted with 20 ml water, and lyophilised. Lyophilised 
peptides were analysed by HPLC using a Vydac 4.6 × 250 mm C4 column, with a gradient of 0-60%B over 30 
minutes at 1 ml/min (A = 0.1% TFA; B = 0.1% TFA, 10% water, 90% acetonitrile) with monitoring at 214 nxn. 
Mass spectra were recorded with a Micromass VG TofSpec E MALDI-TOF mass spectrometer using a 
saturated solution of cc-cyano-4-hydroxycinnamic acid in a 1:2 v/v mixture of HPLC solvents A and B as 
matrix. 
(RGG)3-G-[Ntl]-PQFVQNINIENLFR-amide (7). PQFVQNINIENLFR-amide (CP1042"55-amide) was 
synthesised on a 0.50 mmole scale using NovaBiochem MBHA resin, amine substitution 0.42 mmole/g. Boc- 
amino acids (2 mmole) were single-coupled except for Ile 5° and Gln 43, which were double coupled after 
ninhydrin assay indicated poor couplings. Following Boc removal, neutralisation (20% diisopropylethylamine 
(DIEA)/DMF), and washing with DMF, linker 6 (2 mmole dissolved in'3 ml NMP with 350 ~l DIEA) was 
coupled to 0.33 mmole of the PQFVQNINIENLFR-[MBHA]-resin for 2 hours. The solubilising peptide 
(RGG)3-G was synthesised onto the linker to give Boc-(RGG)3-G-[Ntl]-PQFVQNINIENLFR-[MBHA]-resin. 
The Boc group was removed with TFA, the peptide-resin neutralised with 20% DIEA/DMF, washed with DMF 
followed by DCM, and dried under vacuum. Following HF cleavage and work-up the crude lyophilised 
(RGG)3-G-[Ntl]-PQFVQNINIENLFR-amide 7 was analysed by HPLC and mass spectrometry, then purified by 
HPLC (47rag dissolved in 7 ml water, Vydac C4 25 × 250 mm, 0-60% B / 60 min at 8 ml/min) to give 10.8 mg 
7. The purified peptide construct 7was analysed by HPLC, mass spectrometry and amino acid analysis. Mass: 
found 2779.0 Da, calc. (MH+) 2779.1 Da. Amino acid analysis (error + 10%): Found (Expected): Asx 3.0 (3), 
Glx 2.8 (3), Gly 6.6 (7), Arg 3.8 (4), Val 1.1 (1), Phe 2.2 (2), Ile 2.3 (2), Leu 1.3 (1), Pro 1.1 (1). 
Base cleavage of (RGG)3-G-[Ntl]- PQFVQNINIENLFR-amide (7). To solutions of I-IPLC-purified 7 
in water (2.2 mg/ml, 189.5 I~l) were added 20.5 ~l of either 1.0 M, 0.I M, or 0.01 M NaOH (final [NaOH] 
0.1 M, 0.01 M and 0.001 M respectively, peptide concentration 2.0 mg/ml). Sixty seconds after base addition 
D. R. Englebretsen, G. T. RobiUard / Tetrahedron 55 (1999) 6623-6634 6633 
the solutions were acidified with I0 pl acetic acid and analysed by HPLC and mass spectrometry. Cleavage 
using 0.01 and 0.001 M NaOH was also studied after 120 seconds. After cleavage using 0.1 M NaOH the 
centrifuged precipitate of CP1042"ss-amide 9 was washed several times with water, with centrifugation after 
each wash. The precipitate was dissolved in acetic acid and analysed by mass spectrometry. Mass: found 
1731.7 Da, talc. (MH+) 1731.9 Da. 
(RGG)3-G-INtII-Alal2-I4-Hmbl-GGORG)4G (11). GG(RG)4G-[PAM]-Polystyrene was synthesised 
using 1.0 mmole ABI Boc-GIy-[PAM] resin, substitution 0.77 mrnole/g, with 2.0 mmole of each Boo-amino 
acid single coupled. The linker 4-hydroxymethylbenzoic acid was activated as its N-hydroxysuccinimide 
(NHS) ester (3 mmole) and coupled to 0.67 mmole of the peptide-resin overnight (ninhydrin test negative). 
Boc-Ala anhydride (1.5 mmole, 2.2 eq) was coupled for 2 hours in the presence of dimethylaminopyridine 
(DMAP, 0.25 eq over resin-bound hydroxyl groups). Following DMF wash and Boc removal a sample of the 
A-[4-Hmb]-GG(RG)4G-[PAM]-resin was HF cleaved for mass analysis. SPPS of Alal2 was continued using 
0.17 mmole of A-[4-Hmb]-GG(RG)4G-[PAM]-resin, with 1 mmole (6 eq) Boe-Ala per single l0 minute 
coupling. A sample of the de-Boc'd AI2-[4-Hmb]-GG(RG)4G-[PAM]-resin was HF cleaved for HPLC and 
mass analysis. The de-Boe'd peptide-resin was washed with 5% DIEA/DMF, then 1 mmole linker 6 and 1 ml 
5% DIEA/DMF were added to give a slurry. Nirthydrin test of the resin after one hour was faintly positive for 
unreacted amine, and so it was washed with 5% DIEA / DMF and 6 (0.5 mmole) was recoupled over another 
hour. Because the ninhydrin test was still faintly positive aRer the second coupling of 6, the resin was capped 
for 10 minutes with acetic anhydride/DIEA in DMF (100pl/1001al/2ml). The solubilising peptide (RGG)3-G 
was synthesised onto the linker (6 eq Boo-amino acid per single l0 minute coupling). After HF cleavage and 
workup the crude lyophilised (RGG)3-G-[Ntl]-Alal2-[4-Hmb]-GG(RG)4G l l was analysed by mass 
spectrometry and HPLC, then purified by HPLC (50 mg dissolved in 7 ml water, Vydac C4 25 × 250 ram, 0- 
40% B / 40 rain at g ml/min) to give 9.0 mg 11. Purified peptide-construct 11 was analysed by HPLC, mass 
spectrometry and amino acid analysis. Mass: found 3075.8 Da, calc. (MH+) 3077.3 Da. Amino acid analysis 
(error + 10%): Found (Expected): Gly 14.6 (14), Ala 11.9 (12), Arg 7.0 (7). 
Base cleavage of (RGG)3-G-[Ntl]-AlaI2-[4-Hmb]-GG(RG)4G (11). Solutions of 11 (2.2 mg/ml, 225 ~tl) 
were treated with 25 }~1 1.0 or 0.10 M NaOH (final concentrations: 11 2 mg/ml, NaOH 0.1 M and 0.01 M 
respectively). After 60 seconds (0.1 and 0.01 M NaOH) or 120 seconds (0.01 M NaOH only) the solutions 
were acidified with acetic acid (10 pl), centrifuged, and the supematants analysed by mass spectrometry and 
HPLC. In the cleavage with 0.1 M NaOH the supematant was removed after centrifugation a d the precipitate 
of Alal2 was washed three times with water. The centrifuged precipitate was suspended in20 ~tl of the MALDI- 
TOF matrix solution and analysed by mass pectrometry. Mass: found 872.0 Da, calc. (MH+) 872.2 Da. 
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